XML 42 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended 86 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2012
Cash Flows From Operating Activities:        
Net loss $ (39,444) $ (14,467) $ (15,221) $ (109,053)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation 2 2 2 10
Loss on disposal of property and equipment 2     2
Stock-based compensation expense 2,515 822 712 5,484
Accretion of discount/premium on investment securities (86)     (86)
Purchased in-process research and development       28,157
Change in fair value of derivative instruments-warrants 1,933 (5,257) (297) (3,621)
Changes in operating assets and liabilities:        
Security deposit (5)     (20)
Accounts payable and accrued expenses 4,442 (2,265) 3,286 6,467
Prepaid expenses and other current assets (484) (66) 64 (1,547)
Total Adjustments 8,319 (6,764) 3,767 34,846
Net Cash used in Operating Activities (31,125) (21,231) (11,454) (74,207)
Cash Flows From Investing Activities:        
Net cash paid on Exchange Transaction       (155)
(Loans to) /Repayment from related parties (1,764) 133 (702) (3,306)
Purchases of available-for-sale securities (20,000)     (20,000)
Additions to property and equipment (28)     (42)
Net Cash (used in) /provided by Investing Activities (21,792) 133 (702) (23,503)
Cash Flows From Financing Activities:        
Capital contribution by shareholders       9
Issuance of common stock       2
Proceeds of sale of common stock 55,862 34,369 7,179 116,406
Proceeds from exercise of warrants   415   415
Proceeds from sale of unregistered common stock to founders       18
Fees and expenses related to sale of common stock (3,774) (2,148) (468) (6,724)
Net Cash provided by Financing Activities 52,088 32,636 6,711 110,126
Net increase (decrease) in cash and cash equivalents (829) 11,538 (5,445) 12,416
Cash and cash equivalents at beginning of period 13,245 1,707 7,152  
Cash and cash equivalents at end of period 12,416 13,245 1,707 12,416
Supplementary disclosure of cash flow information:        
Cash paid for taxes 50 38 31 140
Supplementary disclosure of non-cash investing and financing activities:        
Value of warrants classified to derivative liability-net   5,094 3,785 8,879
Value of common stock issued to induce stockholders to extend lock-up agreements     $ 3,235 $ 3,235